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Abstract: Geoditin A, an isomalabaricane triterpene isolated from marine sponge Geodia 
japonica, has been demonstrated to induce apoptosis in leukemia HL60 cells and human 
colon HT29 cancer cells through an oxidative stress, a process also interfering with normal 
melanogenesis in pigment cells. Treatment of murine melanoma B16 cells with geoditin A 
decreased expression of melanogenic proteins and cell melanogenesis  which  was 
aggravated with adenylate cyclase inhibitor SQ22536, indicating melanogenic inhibition 
was mediated through a cAMP-dependent signaling pathway. Immunofluorescence 
microscopy and glycosylation studies revealed abnormal glycosylation patterns of melanogenic 
proteins (tyrosinase and tyrosinase-related protein 1), and a co-localization of tyrosinase 
with calnexin (CNX) and lysosome-associated membrane protein 1 (LAMP-1), implicating 
a post-translational modification in the ER and a degradation of tyrosinase in the lysosome. 
Taken together, potent anti-melanogenic property and the relatively low cytotoxicity of 
geoditin A have demonstrated its therapeutic potential as a skin lightening agent. 
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1. Introduction  
Melanocytes are the major cell population in the skin epidermis which is responsible for melanin 
production and pigmentation of skin and hair. Melanin is synthesized in melanocytes upon ultraviolet 
irradiation and then transported to surrounding epidermal keratinocytes for absorption of energy and 
protection from sunburn. However, abnormal melanogenesis causes pigmentary disorders,  such as 
hyperpigmentation (melasma and lentigines) or hypopigmentation (vitiligo and albinism), which are of 
clinical and cosmetic concerns. Melanogenic agents are commonly employed to modulate melanogenesis. 
Many widely used lightening compounds such as kojic acid or arbutin are isolated from natural sources 
or botanical extracts [1]; few were of marine origin [2], despite its tremendous biological and structural 
diversity [3].  
Melanogenesis is the process of pigment formation initiated by the rate-limiting enzyme tyrosinase 
that converts L-DOPA to dopaquinone before further oxidation to melanin. Activation of tyrosinase is 
associated with phosphorylation by protein kinase C-beta (PKC-β)  and  formation  of  a  complex 
between phosphorylated tyrosinase and tyrosinase-related protein 1 (TYRP1) [4]. In melanocytes, 
converging external stimuli stimulates adenylyl cyclase to raise cAMP that subsequently activates 
microphthalmia-associated transcription factor (MITF), a transcription factor for all melanogenic 
proteins, including tyrosinase (TYR), TYRP1,  tyrosinase-related protein 2 (TYRP2),  and PKC-β. 
MITF is thus a key factor linking both PKC-β- and cAMP-dependent pathways in the regulation of 
melanogenesis [5]. Reduction of MITF binding to the promoters of these melanogenic proteins results 
in a decrease of cell pigmentation. Furthermore, MITF is also the master regulator for DNA 
replication, proliferation and genomic stability of melanoma cells and its reduction leads to DNA 
damage and defective cell replication [6]. The precise function(s) of TYRP2  in melanogenesis, a 
DOPA-chrome tautomerase, remains largely unknown although it decreases cell sensitivity to 
oxidative stress and also modulates melanoma cell sensitivity to chemotherapy [4,7].  
Reactive oxygen species (ROS) are not only by-products of normal cell metabolism but also act as 
signaling molecules in cell functions. An excessive ROS production causes damage of DNA, proteins 
and lipids, ultimately resulting in apoptosis and cell death. In melanocytes, intracellular ROS at 
sublethal concentrations induce melanogenesis [8] through activation of apurinic/apyrimidinic 
endonuclease (APE) for oxidative DNA damage repair [9,10] and promotion of cell survival via MITF 
pathway [9]. Interestingly, kojic acid, a widely used skin whitening agent, possesses both anti-tyrosinase 
and ROS scavenging activities [11].  
Geoditin A, an isomalabaricane triterpenoid isolated from many genera of marine sponges, has 
received special pharmaceutical attention because it inhibited cyclin-dependent kinase activity and 
subsequently suppressed tumor cell proliferation [12,13]. Our previous studies have also demonstrated 
geoditin A being a potent inducer of oxidative stress and apoptosis in HT29 cells [14] and HL60  
cells [15]. It is the objective in this study to investigate if this oxidative stress might interfere with 
tyrosinase activity and melanogenesis in murine B16 melanoma cells. 
2. Results and Discussion 
Geoditin A (Figure 1) is an isomalabaricane triterpene isolated from a South China Sea sponge, 
Geodia japonica [16]. This rare class of triterpenoids possesses potent tumor inhibitory activities [17,18], 
and thus received special attention for its potential for chemotherapeutic development [19].  Mar. Drugs 2012, 10  
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Figure 1. Chemical structure of geoditin A. 
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The values of IC50 for cancer cell lines ranging from 0.1–20 µg/mL which were 2–3 folds higher 
than that for human fibroblasts (IC50 = 60 μg/mL) [14]. Our previous study has also demonstrated a 
potent cytotoxicity of geoditin A against human leukemia HL60 cells (IC50 = 3 µg/mL) [15], but mild 
to human colon carcinoma HT29 cells (IC50 = 20 μg/mL) [14]. The IC50 for murine melanoma B16 
cells in this study also falls in this range, with the value of ≈10 μg/mL (Figure 2a). In addition to its 
cytotoxicity, geoditin A also interfered with L-DOPA conversion activity, a parameter indicative of 
melanogenesis, which decreased dramatically from 80% at 0.625 µg/mL to 25% at 5 µg/mL, with an 
EC50 value  of  about  1 μg/mL. EC50 value is defined as the effective concentration of geoditin A 
required to inhibit half maximal inhibition of L-DOPA conversion, and the ratio of L-DOPA 
conversion to cell viability is defined as melanogenic activity (Figure 3a). Since an effective activity 
was achieved between 1.25 µg/mL to 5 µg/mL when most of the tested cells (≥80%) remained viable, 
the following study was therefore focused on this range. 
Figure 2. (a) Viability and melanogenic activity of geoditin A on murine melanoma B16 
cells. Cells were incubated in 96-well plates with serial concentrations of geoditin A for 
48 h, and their  viability was assessed  by sulforhodamine B (SRB) colorimetric assay. 
Another set of cells were lysed with 20 mM Tris base (pH 7) and reacted with L-DOPA for 
cellular tyrosinase activity (i.e., conversion of L-DOPA into dopaquinone) assay. Results 
were presented as mean and standard deviation of triplicates. (b) Melanin in cell lysates 
was pelleted and extracted with 1 M NaOH before the optical density absorbance  of 
melanin solutions was determined at 490 nm. The melanin contents normalized to cellular 
protein content decrease in a dose-dependent manner. Results were presented as mean and 
standard deviation of triplicates.  
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Instead of using MTT cytotoxicity assay for HL60 cells and HT29 cells in previous studies, 
sulforhodamine B (SRB) colorimetric viability assay [20] was used in this study because the Mar. Drugs 2012, 10  
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absorbance wavelength of the melanin might interfere with that of methyl tetrazolium for MTT assay. 
In consistent with the prominent decrease of L-DOPA conversion activity in B16 cells after geoditin A 
treatment, levels of intracellular melanin content, the end product of this melanogenesis, also reduced 
in a dose-dependent manner (Figure 2b). 
Since geoditin A is an oxidative stressor and ROS is closely associated with melanogenesis, it is 
tempting to speculate that oxidative stress may interfere with pigmentation in B16 cells. This 
inhibitory effect can partially be attenuated by pre-treatment with 10 µM N-acetylcysteine (NAC) 
(Figure 3a), an oxidative scavenger also effectively reducing apoptosis in HT29 cells [14]. 
Interestingly, no noticeable ROS production was measured until B16 cells were exposed to higher 
doses of geoditin A (≥10 µg/mL) thereby ROS production increased by about 3.5 folds (Figure 3b), 
which suggested that ROS might not contribute to anti-melanogenic activity of geoditin A at doses  
≤5 µg/mL. On the other hands, anti-melanogenesis was aggravated by SQ22536, an adenylate cyclase 
inhibitor (Figure 3c); implicating that geoditin A-mediated melanogenesis is regulated through 
modulation of cAMP pathway. When excessive ROS production overwhelms cell tolerance at doses of 
geoditin A ≥10 μg/mL, cells committed to cell death (Figure 2a), probably from apoptosis induced by 
oxidative stress as happened to HT29 cells and HL60 cells [14,15]. 
Figure 3.  (a)  Melanogenic activity (=ratio of L-DOPA conversion to viable cells) by 
geoditin A on B16 cells. Cells incubated in 96-well plates with geoditin A, ranging from 
0.625 to 5 μg/mL, for 48 h was only slightly attenuated by pre-treatment with 10 µM  
N-acetylcysteine (oxidant scavenger). (b) Flow cytometric analysis revealed a low level of 
ROS production in cells treated with geoditin A at doses ≤5 µg/mL until an about 3.5-fold 
increase was measured at dose of 10 µg/mL whose production was greatly attenuated in the 
presence of 10 µM of NAC. Results were presented as mean and standard deviation of 
triplicates.  (c)  Inhibition of intracellular cyclic adenosine monophosphate (cAMP)   
by  pre-incubation for 30 min with specific inhibitor SQ22536 (100 µM) further  
reduced  melanogenic activity, indicating cAMP pathway is involved in geoditin-A  
mediated melanogenesis. 
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Double-label immunofluorescence microscopy has demonstrated a dose-dependent decrease of 
tyrosinase (Figure 4a–d) and cytosolic melanin (Figure 4e–h) in B16 cells treated with geoditin A, 
particularly at dose of 5 μg/mL (Figure 4d,h). No co-localization of tyrosinase with golgin-97, marker 
protein for the Golgi, indicate retention of tyrosinase in this organelle is unlikely (Figure 4b–d). Mar. Drugs 2012, 10  
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Figure 4. Dual immunofluorescence localization of tyrosinase with the Golgi marker in 
B16 cells. Cells were treated with serial concentrations of geoditin A for 48 h, fixed in 3% 
paraformaldehyde and incubated with an  antibody  against golgin-97 (a–d),  the  marker 
protein for the Golgi apparatus. Immunofluorescence was visualized by secondary 
antibody IgG conjugated to Alexa-488 (green) and Alexa-594 (red). Nuclei were 
counterstained with DAPI (blue). Typical Golgi stack (golgin-97, red) is shown at the 
juxtanuclear region while tyrosinase (green) in the cytoplasm of the untreated B16 cells (a) 
which was decreased in a dose-dependent manner (b, c, and d for 0.6, 1.25 and 5 μg/mL, 
respectively). Melanin granules also decreased in a dose-dependent manner after geoditin A 
treatment (e–h) under the phase contrast microscope (scale bar = 100 μm). No apoptotic 
bodies were found in DAPI-stained cells of all treatment groups (0.6–5 μg/mL)(b–d). 
 
 
However, a strong immunofluorescence tyrosinase was co-localized with CNX (Figure 5b–d) and 
LAMP-1 (Figure 5f–h), not only indicating its retention in the ER and lysosomes, but also a possibility 
of improper trafficking of this enzyme to the lysosome for degradation. This phenomenon was also 
found in mouse melanocyte melan-a cells treated with progesterone (Figure 5i) [21], or B16 cells 
treated with inulavosin, a flavanol isolated from Inula nervosa [22]. 
The initial catalytic reaction of melanogenesis (a physiological process of melanin biosynthesis) is 
regulated by the rate-limiting enzyme, tyrosinase, and its related proteins, TYRP1 and TYRP2 [23]. 
Tyrosinase is activated when it is glycosylated, phosophorylated and forming a complex with TYRP1 
in organelles along the melanogenic pathway, namely endoplasmic reticulum, the Golgi and the 
melanosome [4,24].  However, tyrosinase has common targeting motifs for melanosomes and 
lysosomes, making it possible to be mistargeted to lysosomes for degradation [25]. Whether this is a 
result of trafficking defect or improper maturation of tyrosinase in geoditin A-treated cells remains 
unclear in this study, and further study is required to elucidate its underlying mechanism. 
a 
 
b  c  d 
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Figure 5. Co-localization immunofluorescence of tyrosinase in ER and lysosomes. Cells 
were treated with geoditin A [untreated (a), 1.25  μg/mL  (b), 2.5  μg/mL (c),  5  μg/mL 
(d) for 48 h], fixed with 3% paraformaldehyde and immunostained with antibodies against 
tyrosinase (green), CNX protein (red) in the ER (a–d) and LAMP-1 (red) in the lysosome 
(e–h). No retention of tyrosinase in the ER and lysosomes as depicted by two separated 
immunostains in cells without geoditin A treatment (a,e), but strong co-localization (yellow) 
was observed in cells with geoditin A treatment (b–d and f–h for CNX and LAMP-1 with 
tyrosinase in the ER and lysosomes, respectively). A co-localized tyrosinase and LAMP-1 
was also shown in melan-a cells treated with progesterone for 4 days as a positive control (i). 
Apoptotic nuclei were observed in DAPI-stained cells treated with higher dose of geoditin A 
(10 μg/mL) for 48 h (scale bar = 100 μm). 
 
 
Members of melanogenic genes, including tyrosinase, TYRP1, and PKC-β, are regulated at their 
transcriptional levels by microphthalmia-associated transcription factor (MITF)  [5]. In addition to 
pigmentation, MITF also promotes pigment cell growth and differentiation [26]. MITF expression is 
activated by agents that elevate the intracellular  level of cAMP [5] or apurinic/apyrimidinic 
endonuclease (APE-1/Ref-1) in response to ROS [10], and thus strong oxidative stress and cAMP 
inhibitors impinging on MITF become targets for depigmentation. Resveratrol is a good example for 
post-translational regulation through cAMP pathway [25]. 
The decrease of immunofluorescence tyrosinase in B16 cells (Figures 4 and 5) after geoditin A 
treatment is further confirmed by immunoblotting for melanogenic proteins (Figure 6). One major 
band for tyrosinase (80 kD) was revealed in untreated B16 cells while a second band for protein of 
smaller size (about 70 kD) increased in a dose-dependent manner in geoditin A-treated cells (Figure 6a). 
These bands represent different degrees of maturation of melanogenic proteins (tyrosinase and 
tyrosinase-related proteins) in the ER [27]. Nascent tyrosinase is glycosylated and properly folded in Mar. Drugs 2012, 10  
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the ER and completely matured in the Golgi before it is secreted to melanosomes for melanogenesis. 
Immature tyrosinase retains  in the ER and bound to chaperones, such as calnexin (CNX) and 
calreticulin. Thus, our immunofluorescence analysis shows a reduced amount of tyrosinase in the 
Golgi and cytoplasm but it bound significantly with CNX, implicating retention of immature 
tyrosinase in the ER (Figure 5b–d). Similar immunoblotting pattern was also found for TYRP1 protein. 
This decrease was not attributed to cell death because there were still about 80% viable cells at 
5 μg/mL when the L-DOPA conversion activity had already reduced to only 30% of the untreated 
control (Figure 2a). 
Figure 6. (a) Expression of melanogenic genes in geoditin A-treated B16 cells. Protein 
lysates of B16 cells treated with geoditin A, ranging from 0 to 5 μg/mL, for 48 h were 
subject to western blotting for examination of levels of melanogenic proteins (TYR, TYRP1, 
TYRP2 and MITF). Images represent results from at least three separated experiments. 
Equal amount of proteins analyzed were normalized with β-actin. (b) Glycosylation study 
of tyrosinase with EndoH and PGNase F digestion shows matured tyrosinase was present 
in untreated B16 cells while aberrant maturation of tyrosinase increased in a dose-dependent 
manner after treatment with geoditin A (1.25, 2.5 and 5 μg/mL) for 48 h. (c) Western 
blotting for kinetic analysis of melanogenic protein expression in B16 cells treated with 
1.25 μg/mL geoditin A for 8–24 h. Two bands for tyrosinase and three bands for TYRP1 
were present in B16 cells, proteins of larger size (~80 kD) represents mature tyrosinase/ 
TYRP1 while bands of smaller size represent immature glycoforms of these two proteins. 
Immature TYR and TYRP1 were prominent after treatment of 1.25 g/mL geoditin A for 8 h, 
while decrease of MITF expression remained at untreated levels until 24 h, which is far 
behind the change of both TYR and TYRP1.  
   
(a)  (b) 
 
(c) Mar. Drugs 2012, 10  
 
 
472 
The  N-glycan processing of tyrosinase in the ER is noteworthy because the immature form 
increased with the expense of its mature forms but the total amount of these proteins did not change 
significantly (Figure 6). The  oligosaccharide added to tyrosinase in the ER can be cleaved by 
endoglycosidase H (EndoH), while those added in both ER and the Golgi can be cleaved by peptide  
N-glycosidase F (PNGase F) [25]. The analysis of tyrosinase pattern by these two endoglycosidases 
demonstrates a strong band with higher molecular weight for mature tyrosinase but an absence of 
immature tyrosinase only in untreated cells. On the other hand, immature and EndoH-sensitive 
glycoforms of tyrosinase increased in B16 cells after geoditin A treatment (Figure 6b), implicating 
aberrant glycosylation was induced by geoditin A that affected melanogenesis of B16 cells. 
Since MITF is a master transcription factor for members of melanogenic proteins, its down-regulation 
should have a direct inhibition on the expression of TYR and TYRP1. However, a kinetic analysis of 
expression of these three proteins in cells treated with 1.25 μg/mL geoditin A (≈EC50) for 8–24 h has 
revealed a significant reduction of expression of TYR and TYRP1 at 8 h which preceded the decrease 
of MITF at 12–24 h, indicating the decrease of TYR and TYRP1 is independent of MITF, and two 
separated pathways might be involved in their decrease (Figure 6c). 
Apart from melanogenic transcription of tyrosinase, MITF also regulates melanocytic proliferation 
and survival by up-regulating expression of anti-apoptotic bcl-2 gene as well as a number of survival 
genes including Pax3, c-kit, Sox9, Sox10 and LEF1 [10]. A depletion of MITF causes defective 
replication and cell senescence and death [6]. B16 cells died with increasing doses of geoditin A when 
the production of oxidants were overwhelmed (Figure 3b) and the level of anti-apoptotic Bcl-2 protein 
decreased in a dose-dependent manner (Figure 6a). Cells probably died by an apoptotic mechanism 
(Figure 5j).  
Of the four marine sponge isomalabaricane triterpenes, namely stellettins A and B, and geoditins A 
and B, tested in HL60 and HT29 cells, the carbonyl group at C-3 position of geoditin A was 
responsible for its strong apoptotic induction activity [18]. However doses of geoditin A inhibiting 
tyrosinase activity (IC50 ≈ 1 μg/mL) far precede those for cell death/apoptosis (≥10 μg/mL), implicating a 
machinery other than apoptosis induction by the carbonyl group may contribute to the down-regulation 
of MITF protein and tyrosinase activity. Experiment is being conducted to elucidate the molecular 
mechanism underlying the anti-tyrosinase activity elicited by geoditin A. 
3. Experimental Section 
3.1. Test Compounds 
Geoditin A (MW  =  450),  an  isomalabaricane triterpene isolated from a marine sponge,   
Geodia japonica [10,16], was dissolved in DMSO to make a stock solution at a concentration of  
40 mg/mL which was then diluted to appropriate concentrations with culture medium before each 
experiment. The final concentration of DMSO did not exceed 0.5% in any experiment. 
3.2. Cell Cultures 
Murine B16F10 melanoma cells (CRL6475, ATCC) were cultured in DMEM medium supplemented 
with 10% fetal bovine serum (FBS), 100 µg/mL streptomycin and 100 IU/mL penicillin at 37 °C in a 
humidified atmosphere of 5% CO2. Mar. Drugs 2012, 10  
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3.3. Cell Cytotoxicity Assay 
Sulforhodamine B (SRB) colorimetric cytotoxicity assay was used in this study [20]. Briefly,   
B16 cells (5000 cells/0.1 mL/well) were treated with a serial dilution of geoditin A (0.6, 1.25, 2.5 and 
5 μg/mL) in 96-well plates (Costar, USA) for 48 h, the reaction was stopped, the proteins were fixed 
by 50% trichloroacetic acid for 30 min at 4 °C, and stained with 0.4% SRB in 1% acetic acid for  
30 min at room temperature. The unbound dye was removed and the cells were rinsed with 1% acetic 
acid for five times, air-dried and the bound dye was dissolved in 100 µL of Tris base (10 mM, pH 10.5). 
The absorbance was measured with a microtiter plate reader (Molecular Devices, Model Emax) at  
570 nm. Data represent the mean values and standard deviations of triplicate assays in at least three 
separate experiments. Cells pre-treated with oxidative scavenger, N-acetylcysteine (NAC) and 
adenylyl cyclase inhibitor SQ22536 [9-(tetrahydro-2-furanyl)-9H-purin-6-amine] were used to study 
the roles of oxidative stress and activation of cAMP in geoditin A-mediated anti-melanogenesis [27].  
3.4. Production of Reactive Oxygen Species 
Sensitive probe, 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA, D399 Molecular Probes, 
Inc., Oregon, USA) was used in this study to analyze ROS induced by geoditin A treatment. Briefly, 
B16 cells were plated at 3 × 10
5/750 µL supplemented RPMI medium in each well of a 6-well culture 
plate overnight, and the cultures were then incubated in PBS containing 10 µM H2DCF-DA for 15 min 
at 37 °C before being stimulated with various doses of geoditin  A  for  4  h. The intensity of the 
fluorescence  for reactive species was measured using a  flow cytometer at excitation/emission at 
488/535 nm. Cells pre-incubated or co-incubated with NAC (10 μM) and SQ22536 (100 μM) before 
geoditin A treatment were used to elucidate the sources of ROS and cAMP production [27]. 
3.5. L-DOPA Conversion Assay 
B16 cells were treated with geoditin A for 48 h before they were rinsed briefly with warm 
phosphate buffer saline (PBS). Cells were then lysed in 100 μL of 20 mM Tris containing 0.1% triton 
x-100, pH7.0, and reacted with equal volume of 1 mg/mL L-DOPA at 37 °C for 4 h. The absorbance at 
490 nm of the reacted mixture for the tyrosinase activity was measured with a microtiter plate reader 
(Molecular Devices, Model Emax) and expressed as percent of untreated controls.  
Part of the cell lysates was used for melanin content measurement  [28]. The lysates were 
centrifuged; protein concentrations of the supernatants were determined using BCA protein assay kit 
(Thermo Scientific Pierce). The pellets were solubilized in 1 M NaOH at 50 °C for 1 h, and the optical 
density absorbance for melanin content was determined at 490 nm with a microtiter plate reader. The 
relative melanin content was normalized to equal amount (μg) of protein.  
3.6. Fluorescence Staining for Morphological Observation  
B16 cells were seeded on sterile coverslips and treated with a serial dilution of geoditin A for 48 h, 
washed briefly with PBS before they were fixed with paraformaldehyde, stained with antibodies 
against (1) tyrosinase, (2) golgin-97, a marker for the Golgi complex, and (3) calnexin, a  lectin 
chaperone bound to the nascent tyrosinase after the addition of two glycans in the ER, followed by Mar. Drugs 2012, 10  
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secondary antibody IgG conjugated to AlexaFluor-488 or AlexaFluor-594 (Figures 4 and 5) in PBS 
buffer. The chromatin was counter-stained with DAPI before the slides were mounted with anti-fade 
for confocal microscopy (Axioskop, Zeiss, Japan) with a 450–490 nm excitation block filter and a  
520 nm barrier filter [15].  
3.7. Immunoblotting Analysis 
B16 cells after 48 h drug exposure were washed with PBS twice, and the total protein lysates were 
obtained in lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 0.2% Triton X-100, 10 µg/mL aprotinin and 
0.5 mM PMSF), and centrifuged at 10,000 rpm at 4 °C for 10 min. Lysates were normalized for 
protein content using the protein assay reagent (500-0006, Bio-Rad Laboratories, USA).  Equal 
amounts of denatured proteins were loaded and separated on a 10% SDS polyacrylamide gel, and were 
then transferred onto a polyvinylene difluoride (PVDF) membrane. After blocking with 2% gelatin, the 
membrane was stained with specific primary antibodies against melanogenic proteins: tyrosinase   
(13-6800 Zymed Laboratories, South San Francisco, CA, USA), tyrosinase-related protein-1 (TYRP1, 
a kind gift of Dr. Vincent Hearing, National Institutes of Health, Bethesda, MD,  USA),  TYRP2  
(sc-25544 Santa Cruz Biotechnology, Santa Cruz, CA, USA), microphthalmia-associated transcription 
factor (MITF, MS-771 Thermo Scientific, USA), bcl-2 (sc492, Santa Cruz Biotechnol.) and β-actin 
(sc-81178 Santa Cruz Biotechnol.), respectively, followed by secondary antibody IgG conjugated to 
horseradish peroxidase in TBS-T buffer. The signals were detected using the ECL™ Plus Western 
Blotting Analysis System (GE healthcare  Bio-Sciences,  Piscataway, NJ, USA),  followed by short 
exposures to Lumi-film Chemiluminescence Detection Film (Roche Diagnostics Corporation, 
Indianapolis, IN, USA). Band intensities were quantified by the software PD Quest (BioRad 
Laboratories, Hercules, CA, USA) and normalized by β-actin [15].  
3.8. Glycosylation Analysis 
Proteins were extracted as described in 3.7. and 10 μg of protein lysates were subjected to enzyme 
digestion by either 100 units of endoglycosidase H (EndoH, P0702S, New England Biolabs, Beverly, 
MA, USA) or 100 units of peptide N-glycosidase F (PNGase F, P0704S, New England Biolabs) at  
37 °C for 1 h according to the conditions specified in the manufacturer’s instruction (New England 
Biolabs). After incubation, the digested protein lysates were separated on a 8% gel and subjected to 
Western blotting using anti-tyrosinase antibody. 
4. Conclusions 
Geoditin A at sublethal doses (≤5 μg/mL) decreased melanogenesis and glycosylation of tyrosinase 
(TYR) in murine B16 melanoma cells in a dose-dependent, but ROS- and MITF-independent manner. 
There is potential in application and development of this marine compound as a skin lightening agent. 
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